richard kim, md, on the use and sequencing of tkis in hepatocellular carcinoma (hcc)
Published 6 years ago • 34 plays • Length 1:34
Download video MP4
Download video MP3
Similar videos
-
1:17
richard kim, md, shares how we can utilize tkis in the management of hepatocellular carcinoma
-
1:14
richard kim, md, discusses pembrolizumab as an effective agent in hcc management
-
1:26
richard kim, md, offers opinion on the redos study and dose escalation of regorafenib
-
1:25
richard finn, md, elaborates on current treatment options & sequencing of tkis in hcc
-
55:56
“update on the treatment of hepatocellular carcinoma and current research” by richard lee, md
-
1:33
richard kim, md, offers analysis of the rainfall study in metastatic gastric & ge junction cancer
-
1:16
richard kim, md, regarding targeted therapies in treatment of cholangiocarcinoma
-
19:03
ac21 - richard kim: which cholangiocarcinoma patients benefit from immunotherapy?
-
4:35
richard s. finn, md, elaborates on promising developments in the second-line treatment of hcc
-
1:18
dr. kim on the evolving treatment landscape of advanced hcc
-
45:53
hepatocellular carcinoma
-
58:40
liver cancer 101 causes, treatments, innovations & access
-
1:02:04
advances in the multidisciplinary medical management of hepatocellular carcinoma
-
1:18
dr. richard kim on administering aflibercept in colorectal cancer
-
10:35
liver cancer, hepatocellular carcinoma, and hepatoma by dr. robert gish.
-
41:21
the role of tyrosine kinase inhibitors and mtor inhibitors
-
1:51
richard k. wood, md
-
19:09
harnessing the kinome: multi-kinase inhibitors for the management of hepatocellular carcinoma
-
0:47
dr. richards on parp inhibition in pancreatic cancer
Clip.africa.com - Privacy-policy